Pathstone Family Office’s BioMarin Pharmaceuticals BMRN Stock Holding History

Pathstone Family Office’s Portfolio BMRN Stock Details BMRN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$290K	Buy
2021 Q1	–	Sell
2020 Q4	$6K	Sell
2020 Q3	$16K	Sell
2020 Q2	$379K	Hold
2020 Q1	$260K	Buy
2017 Q2	–	Sell
2017 Q1	$1K	Buy